Drostanolone Enanthate is a synthetic anabolic steroid derived from dihydrotestosterone, and was first developed in the late 1950s for medical applications. The primary use was to treat muscle wasting diseases and certain cancers. The enanthate version provides extended action, allowing for less frequent administration. Its popularity increased among fitness enthusiasts due, to its ability to enhance muscle mass and strength while reducing effects on the body. Despite its efficacy in performance enhancement its categorization as a controlled substance raises worries regarding misuse and potential health risks sparking discussions about its use, in treatment and sports.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Drostanolone Enanthate 200 by Somatrop-Lab, consult with your doctor or healthcare professional.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.